pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Scope of breast ultrasound examination in estimating the efficiency of treating a diffuse mastopathy with vitamin D

    Редактор | 2022, Original articles, Practical medicine part 20 №1. 2022 | 4 марта, 2022

    L.I. MALTSEVA¹, YU.V. GARIFULLOVA²

     ¹Kazan State Medical Academy — Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan

    ²Kazan State Medical University, Казань, Kazan

     Contact details:

    Maltseva L.I. — MD, Professor of the Department of Obstetrics and Gynecology

    Address: 36 Butlerov St., Kazan, Russian Federation, tel.: +7 (843) 236-46-41, e-mail: laramalc@mail.ru

     The purpose — to estimate the efficiency of treating a diffuse mastopathy (DM) with vitamin D based on the analysis of the dynamics of gland tissue thickness by the data of ultrasound examination.

    Material and methods. 92 patients with DM and 124 women without breasts pathology were examined. They underwent physical examination, ultrasound of breasts with measurement of gland tissue, digital mammography, levels of vitamin D and prolactin in blood. Measurement of the gland tissue thickness was carried out before starting therapy and 6 months after treatment.

    Results. Correction of the existing deficit of vitamin D leads to a significant decrease of the gland tissue thickness and reflects normalization of the architectonics of breasts.

    Conclusion. Estimation of the gland tissue thickness during the DM with vitamin D is a highly informative and available method of dynamic observation of the treatment efficiency.

    Key words: mastopathy, vitamin D, ultrasound.

    REFERENCES

    1. Mal’tseva, L.I., Garifullova Yu.V. Clinical and genetic parallels of vitamin D supply and benign diseases of the mammary glands. Akusherstvo i ginekologiya, 2018, no. 1,  pp. 91–95 (in Russ.).
    2. Nuria Estébanez, Inés Gómez-Acebo, Camilo Palazuelos et al. Vitamin D exposure and Risk of Breast Cancer: a meta-analysis. Scientific Reports, 2018,  vol. 8,  p. 9039. DOI: 2.10.1038/s41598-018-27297-1
    3. Pigarova E.A., Rozhinskaya L.Ya., Belaya Zh.E., Dzeranova L.K., Karonova T.L., Il’in A.V. et al. Clinical guidelines of the Russian Association of Endocrinologists for the diagnosis, treatment and prevention of vitamin D deficiency in adults. Problemy endokrinologii, 2016,  vol. 62, no. 4,  pp. 60–84 (in Russ.).
    4. Swami S., Kishnan A.V., Feldman D. 1,25-Dihydroxyvitamin D downregulates estrogen receptor abundance and suppress estrogen actions in MCF-7 human breast cancer cells. Clin. Cancer. Res, 2000,  vol. 6 (8),  pp. 3371–3379.
    5. Welsh J., Wietzke J.A., Zinser G.M., Byrne B., Smith K., Narvaez C.J. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr, 2003,  vol. 133 (7 Suppl),  pp. 2425S–2433S.
    6. Banerjee P., Chatterjee M. Antiproliferative role of vitamin D and its analogs — a brief overview. Mol Cell Biochem, 2003,  vol. 253,  pp. 247–254.
    7. Lundqvist J., Kirkegaard T., Laenkholm A.V. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D (3). J. Steroid. Biochem. Mol. Biol, 2017, vol. 177,  pp. 171–178.
    8. Mal’tseva L.I., Garifullova Yu.V., Kalinkina M.G. The role of vitamin D in reducing the density of the mammary glands in women with a diffuse form of mastopathy. Prakticheskaya meditsina, 2018,  vol. 16, no. 6,  pp. 111–117 (in Russ.).
    9. Kogan I.Yu., Polyanin A.A., Myasnikova M.O., Tarasova M.A., Solntseva I.A. Mastopathy (fibrocystic disease): diagnostic approaches. Zhurnal akusherstva i zhenskikh bolezney, 2004,  iss. 2,  pp. 60–65 (in Russ.).
    10. Kogan I.Yu. Mastopathy: new approaches to diagnostics and pathogenetic therapy. Zhurnal akusherstva i zhenskikh bolezney, 2010,  vol. LIX, vyp. 1,  pp. 66–70.
    11. Solomonova A.M. Prognostic significance of diagnostic criteria for evaluating the effectiveness of treatment of diffuse hyperplastic processes of the mammary gland. Vrach-aspirant, 2014,  vol. 65, no. 4.3,  pp. 355–363 (in Russ.).
    12. Shakhov B.E., Terent’eva O.I. Results of dynamic monitoring of the state of the mammary glands in women who have taken hormone replacement therapy for five years according to ultrasound data. Meditsinskiy al’manakh, 2014, no. 5 (35), November, pp. 179–181 (in Russ.).
    13. Fisher U., Baum F. Mammografiya: 100 klinicheskikh sluchaev, per. s angl. [Mammography: 100 clinical cases, transl. from English.]. Moscow: MEDpress-inform, 2009. 368 p.
    14. Garifullova Yu.V. Klinicheskoe znachenie vitamina D v techenii i progressirovanii mastopatii u zhenshchin: avtoref. dis. … kand. med. nauk [Clinical significance of vitamin D in the course and progression of mastopathy in women. Synopsis of dis. PhD med. sciences]. Volgograd, 2019. 24 p.

    Метки: 2022, L.I. MALTSEVA, mastopathy, Practical medicine part 20 №1. 2022, ultrasound, vitamin D, Yu.V. GARIFULLOVA

    ‹  Body composition in children with inflammatory bowel disease Emergency prevention of tick-borne encephalitis in children: retrospective analysis and clinical cases ›
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©